Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Myo-inositol trispyrophosphate-mediated hypoxia reversion controls pancreatic cancer in rodents and enhances gemcitabine efficacy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 134, Issue 11, Pages 2572-2582
Publisher
Wiley
Online
2013-11-11
DOI
10.1002/ijc.28597
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stable tumor vessel normalization with pO2 increase and endothelial PTEN activation by inositol trispyrophosphate brings novel tumor treatment
- (2013) Claudine Kieda et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Autophagy mediates survival of pancreatic tumour-initiating cells in a hypoxic microenvironment
- (2012) Vanessa Rausch et al. JOURNAL OF PATHOLOGY
- Myo-InositolTrisPyroPhosphate Treatment Leads to HIF-1α Suppression and Eradication of Early Hepatoma Tumors in Rats
- (2011) Marc Aprahamian et al. CHEMBIOCHEM
- Mapping Climate Change Vulnerabilities to Infectious Diseases in Europe
- (2011) Jan C. Semenza et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Hypoxia: Adapting to High Altitude by Mutating EPAS-1, the Gene Encoding HIF-2α
- (2011) Martha C. Tissot van Patot et al. HIGH ALTITUDE MEDICINE & BIOLOGY
- Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells
- (2011) Andrea Facciabene et al. NATURE
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
- (2011) Peter Carmeliet et al. NATURE REVIEWS DRUG DISCOVERY
- Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma
- (2010) Guichun Huang et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Radiosensitization and Stromal Imaging Response Correlates for the HIF-1 Inhibitor PX-478 Given with or without Chemotherapy in Pancreatic Cancer
- (2010) D. L. Schwartz et al. MOLECULAR CANCER THERAPEUTICS
- Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1PV
- (2009) A. L. Angelova et al. CLINICAL CANCER RESEARCH
- Selective Killing of Hypoxia-Inducible Factor-1-Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
- (2009) S. Kizaka-Kondoh et al. CLINICAL CANCER RESEARCH
- Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
- (2009) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer
- (2008) Atsushi Masamune et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Neoadjuvant and adjuvant strategies for pancreatic cancer
- (2008) P. Ghaneh et al. EJSO
- Pancreatic Neuropathy and Neuropathic Pain—A Comprehensive Pathomorphological Study of 546 Cases
- (2008) Güralp O. Ceyhan et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More